Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation.
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D016859:Lipoxygenase Inhibitors; D008297:Male; D008545:Melanoma / Q000201:enzymology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000201:enzymology; D014176:Protein Biosynthesis / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology*; D047069:Pyrazolones
D016859:Lipoxygenase Inhibitors; D011720:Pyrazoles; D047069:Pyrazolones; C018845:nafazatrom